About Us

̽»¨ÊÓÆµ is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat cancer patients. With proven leadership and therapeutic radiopharmaceutical expertise, ̽»¨ÊÓÆµ has a strong pipeline of precision targeted radiopharmaceuticals. The initial focus is on prostate cancer with plans to expand to additional cancer types.
The approach of ̽»¨ÊÓÆµ is to build on the progress seen with first generation radiopharmaceuticals with unique, targeted radio hybrid agents.
UKBET-rh-2400004